Disc Medicine (NASDAQ: IRON) legal chief exercises options, sells 7,500 shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Disc Medicine Chief Legal Officer Rahul Khara reported an exercise-and-sell transaction in company common stock. On June 18, 2026, he exercised stock options to acquire 7,500 shares at an exercise price of $14.69 per share, then sold 7,500 shares in open-market trades at weighted average prices between about $69.35 and $71.81. The filing states these sales were made under a pre-arranged Rule 10b5-1 trading plan. Following the transactions, he directly holds 59,673 shares of Disc Medicine common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 7,500 shares ($526,661)
Net Sell
5 txns
Insider
Khara Rahul
Role
Chief Legal Officer
Sold
7,500 shs ($527K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 7,500 | $0.00 | -- |
| Exercise | Common Stock | 7,500 | $14.69 | $110K |
| Sale | Common Stock | 5,400 | $69.9423 | $378K |
| Sale | Common Stock | 1,600 | $70.7257 | $113K |
| Sale | Common Stock | 500 | $71.622 | $36K |
Holdings After Transaction:
Stock Option (Right to Buy) — 57,304 shares (Direct, null);
Common Stock — 59,673 shares (Direct, null)
Footnotes (1)
- The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.35 to $70.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.40 to $71.38, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.45 to $71.81, inclusive. The shares underlying this option are fully vested and exercisable as of the date hereof.
Key Figures
Shares sold: 7,500 shares
Sale prices: $69.35–$71.81 per share
Weighted average prices: $69.9423, $70.7257, $71.6220
+4 more
7 metrics
Shares sold
7,500 shares
Open-market sales of common stock on June 18, 2026
Sale prices
$69.35–$71.81 per share
Price ranges for multiple sale transactions on June 18, 2026
Weighted average prices
$69.9423, $70.7257, $71.6220
Three reported weighted average sale prices for common stock
Options exercised
7,500 shares
Stock option exercise converting into common stock
Option exercise price
$14.69 per share
Exercise price for 7,500 stock options
Shares owned after
59,673 shares
Direct common stock holdings following June 18, 2026 transactions
Net share change
-7,500 shares
NetBuySellShares from transactionSummary (net-sell direction)
Key Terms
Rule 10b5-1 trading plan, weighted average price, Stock Option (Right to Buy), derivative security, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on March 19, 2026."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy)"
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
open-market sale financial
"Sale in open market or private transaction"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
What did Disc Medicine (IRON) insider Rahul Khara report in this Form 4?
Rahul Khara reported exercising stock options and selling common shares of Disc Medicine. He exercised 7,500 options at $14.69 per share, then sold 7,500 shares in open-market trades under a Rule 10b5-1 plan, and now directly holds 59,673 shares.
What stock options did Rahul Khara exercise in Disc Medicine (IRON)?
He exercised stock options covering 7,500 shares of Disc Medicine common stock. The options had an exercise price of $14.69 per share and were fully vested and exercisable as of the transaction date, according to the disclosure in the Form 4 footnotes.